Suppr超能文献

氟哌啶醇、利血平、左旋多巴和金刚烷胺治疗亨廷顿舞蹈病(作者译)

[Haloperidol, reserpine, l-dopa and amantidine in the treatment of Huntington chorea (author's transl)].

作者信息

Candelise L

出版信息

Riv Patol Nerv Ment. 1976 Jan-Feb;96(1):54-62.

PMID:134449
Abstract

Two drugs that should reduce striatal dopamine activity (haloperidol and reserpine) and two other drugs that should increase it (L-Dopa and amantadine) have been successively adminstered to six patients suffering from Huntington's Chorea. The most effective treatment in reducing hyperkinesis was haloperidol, followed by reserpine. Treatment with L-Dopa did not have appreciable effect, on this type of involuntary movements. Against some theoretical expectations administration of amantadine was followed by a slight improvement in the control of involuntary activity.

摘要

已先后对六名患有亨廷顿舞蹈症的患者施用了两种应能降低纹状体多巴胺活性的药物(氟哌啶醇和利血平)以及另外两种应能增加纹状体多巴胺活性的药物(左旋多巴和金刚烷胺)。在减轻运动亢进方面最有效的治疗药物是氟哌啶醇,其次是利血平。左旋多巴治疗对这类不自主运动没有明显效果。与一些理论预期相反,施用金刚烷胺后,不自主活动的控制略有改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验